EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Jan. 16, 2023 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical know-how firm creating revolutionary therapies to revive motion, independence, and well being in individuals with spinal cord injury, in the present day introduced that administration will take part within the following occasions within the upcoming weeks:
- Degroof Petercam Healthcare Convention
January 26, 2023
Brussels, BelgiumDave Marver, CEO, will take part in 1:1 conferences.
- TechShare by Euronext
January 27, 2023
Rotterdam, NetherlandsDave Marver will ship the keynote handle on the annual IPO academic program organized by Euronext.
- BioCapital Europe
March 9, 2023
Amsterdam, NetherlandsDave Marver will give an organization presentation.
- Oppenheimer 33rd Annual Healthcare Convention
March 13-15, 2023
Digital occasionDave Marver or Lara Smith Weber, CFO, will give an organization presentation.
- VFB Taking place (Flemish Federation of Buyers)
March 25, 2023
Ghent, BelgiumDave Marver will give an organization presentation.
Data on upcoming conferences is obtainable within the Investor part of the ONWARD web site at https://ir.onwd.com/news-events.
About ONWARD Medical
ONWARD is a medical know-how firm creating revolutionary therapies to revive motion, independence, and well being in individuals with spinal cord accidents. ONWARD’s work builds on greater than a decade of primary science and preclinical analysis performed on the world’s main neuroscience laboratories. ONWARD’s ARC Remedy, which may be delivered by implantable (ARC-IM) or exterior (ARC-EX) programs, is designed to ship focused, programmed spinal cord stimulation to revive motion and different features in individuals with spinal cord injury, in the end bettering their high quality of life.
ONWARD has obtained 5 Breakthrough Machine Designations from the U.S. FDA encompassing each ARC-IM and ARC-EX. ARC-EX is an exterior, non-invasive platform consisting of a wearable stimulator and wi-fi programmer. Optimistic top-line information have been reported in September 2022 from the corporate’s first pivotal examine, referred to as Up-LIFT, evaluating the power of transcutaneous ARC Remedy to enhance higher extremity energy and performance. The corporate is now getting ready advertising approval submissions for the U.S. and Europe. ARC-IM consists of an implantable pulse generator and lead positioned close to the spinal cord. The corporate accomplished its first-in-human use of the ARC-IM neurostimulator in Could 2022.
ONWARD is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Middle in Lausanne, Switzerland, and has a rising U.S. presence in Boston, Massachusetts. The corporate has an educational partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Expertise (EPFL) and Lausanne College Hospital (CHUV). For extra details about the corporate, please go to ONWD.com. To entry our 2023 Monetary Calendar, please go to IR.ONWD.com.
For Firm Enquiries:
For Media Enquiries:
MC Companies AG
US: Laurie Doyle, P: +1 339 832 0752
Europe: Dr. Johanna Kobler, Katja Arnold, Kaja Skorka, P: +49 89 210 228 0
For Investor Enquiries:
Sure statements, beliefs and opinions on this press launch are forward-looking, which replicate the Firm or, as acceptable, the Firm administrators’ present expectations and projections about future occasions. By their nature, forward-looking statements contain a number of dangers, uncertainties, and assumptions that would trigger precise outcomes or occasions to vary materially from these expressed or implied by the forward-looking statements. These dangers, uncertainties, and assumptions may adversely have an effect on the result and monetary results of the plans and occasions described herein. A mess of things, together with, however not restricted to, adjustments in demand, competitors, and know-how, could cause precise occasions, efficiency, or outcomes to vary considerably from any anticipated improvement. Ahead-looking statements contained on this press launch concerning previous traits or actions shouldn’t be taken as a illustration that such traits or actions will proceed sooner or later. As a outcome, the Firm expressly disclaims any obligation or endeavor to launch any replace or revisions to any forward-looking statements on this press launch as a results of any change in expectations or any change in occasions, situations, assumptions, or circumstances on which these forward-looking statements are based mostly. Neither the Firm nor its advisers or representatives nor any of its subsidiary undertakings or any such particular person’s officers or staff ensures that the assumptions underlying such forward-looking statements are free from errors nor does both settle for any duty for the long run accuracy of the forward-looking statements contained on this press launch or the precise prevalence of the forecasted developments. You shouldn’t place undue reliance on forward-looking statements, which communicate solely as of the date of this press launch.
Supply: ONWARD Medical
2023 GlobeNewswire, Inc., supply Press Releases